{{Enzyme
|celltype=Enhanced in Langerhans cells;Enhanced in dendritic cells;Enhanced in monocytes
|celltype_source=HPA
|celltype_source_key=ENSG00000086062
|description=Attach beta 4 Gal to GlcNAc.
|disease=B4GALT1-CDG;Combined low LDL and fibrinogen;Congenital disorder of glycosylation, type IID
|disease_source=HPO
|disease_source_key=2683
|genename=B4GALT1
|iscdg=true
|ortholog=B4galt1
|phenotype=Abnormal bleeding;Abnormal circulating enzyme concentration or activity;Abnormal facial shape;Abnormal isoelectric focusing of serum transferrin;Abnormality of the coagulation cascade;Autosomal recessive inheritance;Cerebellar hypoplasia;Congenital onset;Dandy-Walker malformation;Decreased LDL cholesterol concentration;Decreased muscle mass;Diarrhea;Edema;Elevated circulating aspartate aminotransferase concentration;Elevated circulating creatine kinase concentration;Elevated hepatic transaminase;Global developmental delay;Hepatomegaly;High myopia;Hydrocephalus;Hypertelorism;Hypofibrinogenemia;Hypothyroidism;Hypotonia;Infantile axial hypotonia;Infantile muscular hypotonia;Inflammatory abnormality of the skin;Inverted nipples;Long philtrum;Low-set ears;Macrocephaly;Myopathy;Myopia;Premature birth;Prolonged partial thromboplastin time;Reduced antithrombin III activity;Reduced protein C activity;Reduced protein S activity;Redundant neck skin;Small for gestational age;Splenomegaly;Thin upper lip vermilion;Type II transferrin isoform profile;Wide nasal bridge
|phenotype_source=HPO
|phenotype_source_key=2683
|species=Human
|tissue=Low tissue specificity
|tissue_source=HPA
|tissue_source_key=ENSG00000086062
|uniprot=P15291
}}
